Fig. 2
From: Targeting phosphoglycerate dehydrogenase in multiple myeloma
PHGDH inhibitors’ effects on proliferation of primary myeloma cells and PBMCs. CTG was used to assess the sensitivity to the inhibitors. a, b Primary cells treated overnight with indicated doses of CBR5884 and NCT-503, respectively. c, d PBMCs treated overnight with indicated doses of CBR5884 and NCT-503, respectively. The graphs and calculated IC50 values represent at least two technical replicates and the error bars are ± SD